Novartis Investigative Site

Normal, Illinois 61761

0 studies enrolling now · 8 studies all time

What they study most

COPD, Chronic Obstructive Pulmonary Disease, Chronic Obstructive Pulmonary Disease (COPD), Chronic Obstructive Pulmonary Disease (COPD) With Cachexia, Chronic Obstructive Pulmonary Disease, COPD, Chronic Plaque-type Psoriasis, Persistent Asthma

Studies at this site

• A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251 — Completed
• Single and Multiple Dose Escalation Study to Assess the Safety and Tolerability of CJM112 in Psoriasis — Completed
• BYM338 in Chronic Obstructive Pulmonary Disease (COPD) Patients With Cachexia — Completed
• Effect of QVA149 Versus NVA237 and Tiotropium on Chronic Obstructive Pulmonary Disorder (COPD) Exacerbations — Completed
• Safety, Tolerability and Efficacy of Indacaterol in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) — Completed
• Efficacy and Safety of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) — Completed
• Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary Disease — Completed
• Efficacy, Safety and Pharmacokinetics of Different Regimens of Indacaterol — Completed